A Study to Evaluate the Effect of Diltiazem on the Pharmacokinetics (PK) of BMS-986141 in Healthy Subjects


Phase 1 Results N/A

Main Contacts

Name Phone E-mail
Bristol-Myers Squibb Study Director
Recruiting sites have contact information. Please contact the sites directly. If there is no contact information, please email: Contact Clinical.Trials@bms.com
First line of the email MUST contain NCT# and Site #. Contact Backup

Contacts by Location

PPD Development Austin, Texas, United States Recruiting_status_icon
Mark Thomas Contact 512-747-4778 mark.thomas@ppdi.com